The latest news in rare cancer tumour types including sarcomas
AACR 2026: Long-term use of immunotherapy may be safe for patients with alveolar soft part sarcoma
Long-term adverse events were rare and manageable among patients with alveolar soft part sarcoma (ASPS), which primarily…